{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:34:16Z","timestamp":1788507256563,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI\/12\/RC\/2275"],"award-info":[{"award-number":["SFI\/12\/RC\/2275"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI\/13\/SP SSPC\/I2893"],"award-info":[{"award-number":["SFI\/13\/SP SSPC\/I2893"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jpba.2017.05.008","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T03:15:13Z","timestamp":1493954113000},"page":"337-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Non-volatile extractable analysis of prefilled syringes for parenteral administration of drug products"],"prefix":"10.1016","volume":"142","author":[{"given":"Noem\u00ed","family":"Dorival-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iben","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jpba.2017.05.008_bib0005","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/17425247.2013.780023","article-title":"Biopharmaceutical formulations for pre-filled delivery devices","volume":"10","author":"Jezek","year":"2013","journal-title":"Expert Opin. Drug Delivery"},{"issue":"10","key":"10.1016\/j.jpba.2017.05.008_bib0010","first-page":"2095","article-title":"Drug prefilled non-reusable syringes as drug-device","volume":"3","author":"Kale","year":"2015","journal-title":"World J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jpba.2017.05.008_bib0015","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/17425247.2014.923400","article-title":"Pre-filled syringe\u2014a ready-to-use drug delivery system: a review","volume":"11","author":"Ingle","year":"2014","journal-title":"Expert Opin. Drug Delivery"},{"issue":"10","key":"10.1016\/j.jpba.2017.05.008_bib0020","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1517\/17425247.2014.928281","article-title":"Extractables and leachables considerations for prefilled syringes","volume":"11","author":"Jenke","year":"2014","journal-title":"Expert Opin. Drug Delivery"},{"issue":"4","key":"10.1016\/j.jpba.2017.05.008_bib0025","first-page":"96","article-title":"Risk management strategies for safety qualification of extractable and leachable substances in therapeutic biologic protein products","volume":"12","author":"Markovic","year":"2009","journal-title":"Am. Pharm. Rev."},{"issue":"1","key":"10.1016\/j.jpba.2017.05.008_bib0030","first-page":"74","article-title":"Extractable and leachable implications on biological products in prefilled syringes","volume":"14","author":"Nashed-Samuel","year":"2011","journal-title":"Am. Pharm. Rev."},{"issue":"11","key":"10.1016\/j.jpba.2017.05.008_bib0035","first-page":"36","article-title":"Recommendations for extractables and leachables testing","volume":"5","author":"Colton","year":"2007","journal-title":"Bioprocess Int."},{"issue":"1-2","key":"10.1016\/j.jpba.2017.05.008_bib0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cite.201200113","article-title":"Determination of Extractables and Leachables for single use systems","volume":"85","author":"Ding","year":"2013","journal-title":"Chem. Ing. Tech."},{"issue":"6","key":"10.1016\/j.jpba.2017.05.008_bib0045","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/j.1523-1755.2005.00340.x","article-title":"The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes","volume":"67","author":"Boven","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.jpba.2017.05.008_bib0050","first-page":"86","article-title":"Technical investigations into the cause of the increased incidence of antibody-mediated pure red cell aplasia associated with Eprex","volume":"5","author":"Sharma","year":"2005","journal-title":"Eur. J. Hosp. Pharm."},{"issue":"1","key":"10.1016\/j.jpba.2017.05.008_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5731\/pdajpst.2012.00803","article-title":"Interactions between therapeutic proteins and acrylic acid leachable","volume":"66","author":"Liu","year":"2012","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"3","key":"10.1016\/j.jpba.2017.05.008_bib0060","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS PharmSciTech."},{"issue":"4","key":"10.1016\/j.jpba.2017.05.008_bib0065","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5731\/pdajpst.2012.00869","article-title":"Evaluation of the general solution compatibility of polymer materials used in medical devices such as syringes","volume":"66","author":"Jenke","year":"2012","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"5","key":"10.1016\/j.jpba.2017.05.008_bib0070","first-page":"16","article-title":"Utility and application of analytical and safety thresholds for the evaluation of extractables and leachables in drug products","volume":"10","author":"Ball","year":"2007","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.jpba.2017.05.008_bib0075","series-title":"Leachables and Extractables Handbook. Safety Evaluation, Qualification, and Best Practices Applied to Inhalation Drug Products","author":"Ball","year":"2012"},{"key":"10.1016\/j.jpba.2017.05.008_bib0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9258(18)86000-8","article-title":"A buffer solution for colorimetric comparison","volume":"49","author":"McIlvaine","year":"1921","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2017.05.008_bib0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.jpba.2017.05.008_bib0090","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jpba.2003.08.003","article-title":"Structural identification of extractables from rubber closures used for pre-filled semisolid drug applicator by chromatography, mass spectrometry, and organic synthesis","volume":"34","author":"Zhang","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2017.05.008_bib0095","first-page":"RA137","article-title":"Estrogen-like endocrine disrupting chemicals affecting puberty in humans\u2014a review","volume":"15","author":"Roy","year":"2009","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jpba.2017.05.008_bib0100","first-page":"109","article-title":"Impact of formulation and processing parameters on silicone extraction from cyclic olefin copolymer (COC) syringes","volume":"65","author":"Shah","year":"2011","journal-title":"PDA J. Pharm. Sci. Technol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517304934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517304934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T03:20:29Z","timestamp":1658978429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517304934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":20,"alternative-id":["S0731708517304934"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.05.008","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-volatile extractable analysis of prefilled syringes for parenteral administration of drug products","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}